Medical Equipment

Bilirubin Blood Test Market Size and Growth Forecast for Businesses 2025–2029

November 17, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Growth Projections For The Bilirubin Blood Test Market Size During 2025–2029?

The overall valuation of the bilirubin blood test sector has experienced robust expansion over the recent past, projected to ascend from its 2024 figure of $1.37 billion to reach $1.46 billion in 2025, reflecting a compound annual growth rate of 6.9%. This upward trajectory during the historical timeframe stems from several key factors, including the rising incidence of hepatic ailments, expansion within neonatal assistance services, progress in diagnostic technology, heightened public consciousness regarding health matters, improvements in medical facilities, the establishment of official mandates and protocols, and a greater uptake of testing solutions situated at the point of patient care.

Anticipation surrounds the bilirubin blood test sector, projecting robust expansion over the forthcoming period, reaching a valuation of $1.94 billion by 2029, propelled by a compound annual growth rate (CAGR) of 7.4%; this upward trajectory is fueled by several key factors, including heightened needs for prompt disease identification, the proliferation of diagnostic facilities, an increase in the prevalence of long-term medical conditions, burgeoning opportunities within developing regions, the incorporation of sophisticated analytical tools, and increased financial support for research endeavors, while notable shifts in the market landscape feature the creation of testing procedures that preclude invasive techniques, the weaving together of testing with digital healthcare platforms, progress in self-administered testing kits, improvements in both the precision and quickness of test results, the adoption of tailored medical treatments, the rise of intelligent diagnostic instrumentation, and the engineering of easily transportable testing apparatus.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18522&type=smp

What Are The Top Growth Drivers Impacting The Bilirubin Blood Test Market Outlook?

Anticipated escalation in the prevalence of hepatic ailments is projected to fuel the expansion of the bilirubin blood testing sector moving ahead. Hepatic ailments encompass diverse conditions that compromise the organ’s appropriate operation, stemming from numerous origins like contagion, excessive alcohol use, or metabolic anomalies. The surge in recorded instances of liver affliction can be linked to escalating obesity statistics, heavy alcohol intake, viral contagions, and detrimental lifestyle patterns, all contributing to hepatic impairment and degradation. Since liver disease profoundly affects subsequent bilirubin concentrations within the organism, these blood assessments prove vital for both identifying and tracking hepatic performance, furnishing healthcare professionals with essential patient health data necessary for the successful administration and therapy of liver-associated problems. To illustrate this trend, data from the European Centre for Disease Prevention and Control, a governmental health body based in Sweden, revealed that for the year 2022, there were 28,855 documented occurrences of hepatitis B virus (HBV) infection reported across 30 EU/EEA Member States, marking a substantial 78 percent rise from the 16,187 cases noted in 2021; moreover, the 28,420 total cases recorded in 2022 translate to an unadjusted incidence rate of 8.5 infections per 100,000 residents, underscoring how the increasing frequency of liver issues is stimulating demand within the bilirubin blood test market.

What Are The Emerging Segments Gaining Attention In The Bilirubin Blood Test Market?

The bilirubin blood testmarket covered in this report is segmented –

1) By Test Type: Total Serum Bilirubin Test, Indirect Or Unconjugated Bilirubin Test, Direct Or Conjugated Bilirubin Test

2) By Age Group: Adults, Pediatrics, Infants

3) By Application: Hospital, Clinic, Other Applications

Subsegments:

1) By Total Serum Bilirubin Test: Routine Screening, Liver Function Assessment, Newborn Jaundice Detection

2) By Indirect Or Unconjugated Bilirubin Test: Hemolytic Anemia Diagnosis, Gilbert’s Syndrome Detection, Monitoring For Preliver Conditions

3) By Direct Or Conjugated Bilirubin Test: Bile Duct Obstruction Diagnosis, Hepatitis And Liver Disease Monitoring, Post-Liver Condition Assessment

What Long-Term Trends Will Shape The Future Growth Of The Bilirubin Blood Test Industry?

Leading firms within the bilirubin blood test sector are increasingly favoring a strategy of forming alliances to broaden their presence and augment the services they provide. This kind of strategic alliance essentially describes a cooperative venture among several entities, pooling their assets, specialized knowledge, and work to meet shared aims. As a concrete illustration, during December 2023, Calmark Sweden AB, a firm specializing in medical diagnostic biotechnology headquartered in Israel, entered into an agreement granting Techno Orbits exclusive rights to distribute Calmark’s bilirubin test, specifically formulated for neonates, across Saudi Arabia. Techno Orbits is now tasked with managing the sales and distribution activities, utilizing its established infrastructure and connections, notably those with the nation’s Ministry of Health. The objective of this collaboration is to expedite the launch of Calmark’s bilirubin assessment tool into the Saudi Arabian region, with the governmental regulatory sign-off anticipated within a time frame spanning three to six months.

Who Are The Prominent Global Companies Shaping The Bilirubin Blood Test Market?

Major companies operating in the bilirubin blood test market are F.Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Koninklijke Philips N.V., Mindray Medical International Limited, Beckman Coulter Inc., Drägerwerk AG and Co. KGaA, Sysmex Corporation, Bio-Rad Laboratories Inc., Konica Minolta Inc., Instrumentation Laboratory LLC, Randox Laboratories Ltd., Ortho Clinical Diagnostics Inc., Natus Medical Incorporated, Nova Biomedical, Advanced Instruments LLC, Helmer Scientific Inc., Reichert Technologies Inc., Rousselet Robatel SAS, Labnet International Inc., AVI Healthcare Pvt. Ltd., Ginevri S.p.A.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/bilirubin-blood-test-global-market-report

Which Region Currently Holds The Largest Share Of The Bilirubin Blood Test Market?

North America was the largest region in the bilirubin blood test market in 2024. The regions covered in the bilirubin blood test market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Bilirubin Blood Test Market Report:

https://www.thebusinessresearchcompany.com/customise?id=18522&type=smp

Browse Through More Reports Similar to the Global Bilirubin Blood Test Market 2025, By The Business Research Company

Anemia And Other Blood Disorder Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/anemia-and-other-blood-disorder-drugs-global-market-report

Blood Transfusion Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report

Stem Cell Cord Blood Banking Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/stem-cell-cord-blood-banking-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795